The foundation to prevent antibiotic resistance
PAR Foundation
In 2017, BioGaia founded the Foundation to Prevent Antibiotic Resistance, also known as the PAR Foundation. PAR is an independent foundation with the aim of preventing antibiotic resistance through support for research, education and information activities.
Antibiotic resistance (AMR) is considered one of the world’s main threats to human health. According to the World Health Organization (WHO), the overuse and misuse of antibiotics in healthcare, livestock, and food production has created a real threat to humanity. A synchronized global action plan is required to avoid a post-antibiotic era, where even common infections may once again become fatal. Greater awareness of public health measures is crucial to maintaining the efficacy of antibiotics today and for future generations.
Since its launch, the PAR Foundation — with support from BioGaia — has distributed SEK 25.6 million across 25 projects worldwide, driving impactful research, education, and advocacy efforts to combat AMR.
In 2024 alone, BioGaia allocated SEK 4.4 million to support the foundation’s efforts. This funding enables projects working to prevent infections among the elderly, as well as education and awareness initiatives in Ecuador, Malaysia, and several African countries to improve knowledge about antibiotic resistance prevention.
Learn more about the foundation and its distributed grants at parfoundation.org.
Follow PAR Foundation
Children’s Mission
BioGaia supports Children’s Mission for their work with poor children and families in the Philippines. Children’s Mission runs schools, offers children opportunities for education and healthcare and runs children’s homes as well as a support program.
Climate Transformation Fund
Since 2013, BioGaia has purchased carbon offsets for the company’s emissions. However, in 2022 the company decided to support the Climate Transformation Fund to maximise the impact of its climate investments.
Panzi hospital
BioGaia, through the organization Friends of Panzi, supports the 2018 Nobel prize laureate Dr Denis Mukwege and his important work at the Panzi Hospital in the Democratic Republic of Congo.